Study Stopped
technical resources not available
Study of the Neural Substrates of Alcohol Craving by High-resolution Electroencephalography
CRAVING-NET
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Alcohol is the most consumed psychoactive substance in France and is responsible for 49,000 deaths per year in the country. Addictions, characterized by "the repeated impossibility of controlling a behavior and the continuation of this behavior despite the knowledge of its negative consequences", are a major public health issue in France and worldwide. Alcohol dependence (DSM-5 moderate to severe use disorder) is a chronic behavioral disorder, whose main characteristic is its high and prolonged risk of "relapse", i.e. the resumption of problematic consumption after a period of improvement (abstinence or reduction). One of the main components of addiction is "craving", which can be defined as the irrepressible desire to use a substance (DSM-5, American Psychiatric Association). To date, despite functional imaging studies (fMRI), the brain mechanisms involved in craving remain poorly understood. In recent years, a new neuroimaging device has become available, both in research and in clinical settings: high-resolution electroencephalography (HRE). This non-invasive method allows to observe brain activity at the millisecond level. The objective of the CRAVING-NET project is to better understand brain function in alcohol addiction, and in particular in craving.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2023
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2022
CompletedFirst Posted
Study publicly available on registry
March 11, 2022
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedDecember 4, 2023
November 1, 2023
2 years
March 2, 2022
November 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Source connectivity within large-scale brain networks
Difference in source connectivity within large-scale brain networks following the induction of craving episodes between alcohol-dependent patients and matched healthy participants (smokers and non-smokers). Source connectivity is measured by the strength of connections between brain regions (ratio value between 0 (no communication) and 1 (strong communication)).
1 day
Secondary Outcomes (5)
Variation in source connectivity based on AUQ
1 day
Variation in source connectivity based on OCDS
1 day
Variation in source connectivity based on psychological state
1 day
Correlation between brain networks estimated by HRE and AUQ and OCDS scores
6 months
Correlation between EEG-HR and fMRI networks at inclusion
1 day
Study Arms (2)
Patients
OTHERPatients hospitalized for rehab. HRE following induction of alcohol craving and questionnaires
Healthy Volunteers
OTHERHealthy Volunteers with non alcohol dependance. HRE following induction of alcohol craving and questionnaires
Interventions
Presentation of images that may induce craving for alcohol. Recording of brain activity
Questionnaires related to alcohol, quality of life, anxiety and depression
Eligibility Criteria
You may qualify if:
- Patients (N=20):
- Subject with moderate to severe DSM-5 alcohol use disorder hospitalized for withdrawal as part of their routine care.
- Presence of spontaneous and/or in response to environmental stimuli (induced) self-described episodes of craving.
- Males with age ≥ 30 years and ≤ 60 years;
- Normal or corrected-to-normal visual acuity (declarative);
- Right-handed;
- Healthy control volunteers (N=40):
- Men with age ≥ 30 years and ≤ 60 years;
- Normal or corrected-to-normal visual acuity;
- Right-handed;
- Smoker (current user, N=20) or Nonsmoker (never smoked, N=20);
- Alcohol consumption below the low-risk drinking threshold (\<10 standard drinks per week)
You may not qualify if:
- For all subjects:
- Alcohol use in the 24 hours prior to the experiment;
- Consumption of psychoactive substances other than tobacco and alcohol (positive urine test).
- Presence of a contraindication related to the MRI technique
- Being under legal protection, and/or deprived of freedom;
- Not mastering the French language (written and oral);
- Inability to understand the information given on the study and/or to carry out the experimental task.
- For patients:
- Presence of cognitive impairment (MoCA score \< 25)
- Absence of spontaneous or induced craving episodes
- Decompensated cirrhosis: ascites and/or encephalopathy and/or jaundice and/or recent hemorrhage
- For healthy control volunteers:
- Significant medical or surgical history related to the central nervous system;
- Current use (\< 30 days) of drugs affecting the central nervous system belonging to the class of antidepressants, sleeping pills and/or anxiolytics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Romain Moirand, Pr
CHU Rennes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2022
First Posted
March 11, 2022
Study Start
May 1, 2023
Primary Completion
May 1, 2025
Study Completion
November 1, 2025
Last Updated
December 4, 2023
Record last verified: 2023-11